HomeFUNDING

FUNDING

Enspectra Health Receives $4.0 Million NIH Grant to Advance a New Field of Virtual Biopsies

Enspectra Health received a Phase IIB award of $4.0 million under the National Institutes of Health's Small Business Innovation Research Program for the continued development of its novel imaging technology to aid in the evaluation of nonmelanoma skin cancers.

Rapid Medical Announces Closing of $50m Series D Financing

Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, announced today that it has completed an oversubscribed Series D financing...

MindPortal Raises $5 Million

MindPortal's wearable platform brain computer will allow people to create, play, connect, control technology and achieve magical new experiences. The visionary startup attracts additional investment from Kleiner Perkins, rockstar Matt Bellamy of Muse, Fitbit CEO James Park, and more.

Lydus Medical Announces $2.7M Seed Round Funding

Pre-A funding, led by a leading US-based strategic player with the participation of Sanara Ventures and existing shareholders.

Healionics Raises $4.7M Equity Round to Support Commercialization of STARgraft Vascular Graft

Healionics is preparing to commercialize its innovative STARgraft vascular graft, designed to provide a safer and more reliable means to access the bloodstream for dialysis in patients with kidney failure.

UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care

The Yozma Group Korea, Atain Specialty Insurance Company and the Weizmann Institute of Science participated in the round.

Aerobiotix Raises $25M Growth Equity Financing Led by Global Healthcare Investment Firm Vivo Capital

The new funding will be used to accelerate sales, marketing, and new product development.

Xtant Medical Announces $20 Million Debt Financing with MidCap Financial

The credit agreements provide for a $12 million secured term loan at a per annum interest rate of 7.00%, plus one-month LIBOR, and an $8 million secured revolving credit facility at a per annum interest rate of 4.50%, plus one-month LIBOR. Both facilities have a five-year term.

Bone Health Technologies Closes $2.5 Million Funding Round

This capital and the expertise we are bringing to bear is exactly what they need to complete our pivotal trial and bring this important innovation to market.